About
Basic Data Updated:
18 days agoIt has been reported that Alembic Pharmaceuticals Limited is currently involved in the production of formulations and bulk drugs for both domestic and international markets. The company has a wide reach, with its generic pharmaceutical products being sold globally. In order to further enhance its capabilities, the company has established a research facility known as Alembic Research Centre (ARC) which includes formulation research and a 150-bed bioequivalence facility in Vadodara, Gujarat. Moreover, the company has also invested in a state-of-the-art R&D center in Hyderabad. In terms of sales, the company primarily focuses on branded formulations for markets outside of India. With a vision to expand its presence in various therapeutic areas such as dermatology, oncology, and injectable formulations, the company is constantly seeking new opportunities. Alembic Pharmaceuticals Limited currently operates 6 formulation and 3 API manufacturing facilities, out of which 5 are located near Vadodara in Gujarat - 3 in Panelav and 2 in Karakhadi. The remaining facility is situated in Sikkim.
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Alembic Pharmaceuticals Limited
Mother Care
Fever
Hair Growth for Men
Mineral Supplements
Financials of Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.3% increase. The company also saw a substantial fall in profitability, with a 36.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.56%.
Corporate Structure
Unlock access to Alembic Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Alembic Pharmaceuticals Limited
Unlock and access historical data on people associated with Alembic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (5)
Pranav Amin
Managing DirectorAppointment Date: 31-Mar-2011
Status: Current
SA
Shaunak Amin Managing DirectorAppointment Date: 02-May-2013
Status: Current
CA
Chirayu Amin CEOAppointment Date: 27-Apr-2016
Status: Current
RB
R Baheti CFOAppointment Date: 28-Jul-2014
Status: Current
MK
Manisha Kathed Company SecretaryAppointment Date: 01-Apr-2023
Status: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2011 | ₹600.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Nov 2021 | ₹5.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 26 Jul 2021 | ₹10.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alembic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alembic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sbi Mutual Fund Trustee Company Private Limited
Active
21 years 4 months Archana Hingorani is a mutual person
Recent activity within the organization
Director Appointment
Manish Santoshkumar Kejriwal was appointed as a Additional Director was appointed as a Additional Director on 16 Apr 2024 & has been associated with this company since 1 month 3 days .
16 Apr 2024Annual General Meeting
Alembic Pharmaceuticals Limited last Annual general meeting of members was held on 04 Aug 2023 as per latest MCA records.
04 Aug 2023Charges
A charge registered on 26 Jul 2021 via Charge ID 100469987 with Yes Bank Limited was fully satisfied on 13 Jun 2023.
13 Jun 2023Director Appointment
Jai Shishir Diwanji was appointed as a Director was appointed as a Director on 05 May 2023 & has been associated with this company since 1 year 16 days .
05 May 2023Balance Sheet
Alembic Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
31 Mar 2023
Recent News, Updates & Announcement
Alembic Pharma shares surge 5 on USFDA product approvals.Moneycontrol 02 Jan 2024
- Manufacturing operations disrupted at Sikkim plant due to flash floods Alembic Pharma.
Flash floods in the Teesta River has led to disruption in operations at its Sikkimbased manufacturing plant said Alembic Pharmaceuticals on Wednesday The company in a regulatory filing said We would like to inform that due to flash floods in river Teesta because of cloud burst water entered our manufacturing facility at Namthang South Sikkim and hence manufacturing operations stand disrupted with effect from October 4 .
Economic Times 04 Oct 2023
- Alembic Pharmaceuticals posts Rs 1206 crore profit in Q1.
Moneycontrol 05 Aug 2023
- Alembic Pharma lowers US sales guidance from 500 mn to 300 mn for next 34 years.
Around 29 per cent of the total business of the Vadodarabased drug maker comes from the US sales which manufactures and markets generic drugs which are reverseengineered cheap versions of branded patented drugs.
Business Today 08 Feb 2023
- Alembic Pharma Q3 net dips 29 to Rs 122 cr revenue rises to Rs 1509 cr.
Business Standard 02 Feb 2023
Frequently asked questions
What is the Incorporation or founding date of Alembic Pharmaceuticals Limited?
